EquityZen Growth Technology Fund LLC - Series 1911
Raised
$2M
Investors
61
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1911 is a Delaware pooled investment fund that raised $2.0M from 61 investors under Rule 506(b) and 3(c)(1) exemptions, filed September 18, 2024. The vehicle is managed by EquityZen Advisors with a $10K minimum investment and is part of EquityZen's pre-IPO access platform comprising 1,889 related EDGAR entities.
This pre-IPO fund follows EquityZen's standard series structure, using the 506(b) private placement exemption with a retail-accessible $10K minimum. The 61-investor count reflects the platform's micro-syndication model enabling broad access to pre-IPO equity positions, typical of the single-company SPV category in this asset class.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
